Complement independent antibody-mediated endarteritis and transplant arteriopathy in mice

American Journal of Transplantation

Volumn 10, Issue 3, 2010, Pages 510-517

  Hirohashi, T ^a   Uehara, S ^a,b   Chase, C M ^a   Dellapelle, P ^c   Madsen, J C ^a   Russell, P S ^a   Colvin, R B ^c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

C4d; Chronic transplant arteriopathy; Complement; Heart transplantation

Indexed keywords

ALLOANTIBODY; COMPLEMENT COMPONENT C4D; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MONOCLONAL ANTIBODY; ANTIBODY; COMPLEMENT; COMPLEMENT C4D; COMPLEMENT COMPONENT C4B; PEPTIDE FRAGMENT;

ACUTE GRAFT REJECTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIAC ALLOGRAFT VASCULOPATHY; CARDIAC GRAFT REJECTION; CHRONIC DISEASE; COMPLEMENT ACTIVATION; COMPLEMENT DEFICIENCY; COMPLEMENT DEPOSITION; COMPLEMENT SYSTEM; CONTROLLED STUDY; CORONARY ARTERY; DISEASE SEVERITY; ENDARTERITIS; FEMALE; GRAFT RECIPIENT; HEART TRANSPLANTATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; ARTERY; C57BL MOUSE; CHEMISTRY; DISEASE COURSE; GENETICS; HEART; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROCEDURES; TIME;

ANIMALS; ANTIBODIES; ANTIBODIES, MONOCLONAL; ARTERIES; COMPLEMENT C4B; COMPLEMENT SYSTEM PROTEINS; DISEASE PROGRESSION; ENDARTERITIS; HEART; HEART TRANSPLANTATION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PEPTIDE FRAGMENTS; TIME FACTORS;

EID: 76949094045     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2009.02958.x     Document Type: Article

References (44)

1. Taylor DO, Edwards LB, Boucek MM et al. Registry of the International Society for Heart and Lung Transplantation: Twenty-second official adult heart transplant report-2005. J Heart Lung Transplant 2005 24 : 945 955.
2. Burke BA, Chavers BM, Gillingham KJ et al. Chronic renal allograft rejection in the first 6 months posttransplant. Transplantation 1995 60 : 1413 1417.
3. Cornell LD, Colvin RB. Chronic allograft nephropathy. Curr Opin Nephrol Hypertens 2005 14 : 229 234.
4. Jeannet M, Pinn VW, Flax MH, Winn HJ, Russell PS. Humoral antibodies in renal allotransplantation in man. N Engl J Med 1970 282 : 111 117.
5. Hourmant M, Cesbron-Gautier A, Terasaki PI et al. Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation. J Am Soc Nephrol 2005 16 : 2804 2812.
6. Terasaki PI, Ozawa M, Castro R. Four-year follow-up of a prospective trial of HLA and MICA antibodies on kidney graft survival. Am J Transplant 2007 7 : 408 415.
7. Feucht HE, Felber E, Gokel MJ et al. Vascular deposition of complement-split products in kidney allografts with cell-mediated rejection. Clin Exp Immunol 1991 86 : 464 470.
8. Mauiyyedi S, Pelle PD, Saidman S et al. Chronic humoral rejection: Identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries. J Am Soc Nephrol 2001 12 : 574 582.
9. Regele H, Bohmig GA, Habicht A et al. Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: A contribution of humoral immunity to chronic allograft rejection. J Am Soc Nephrol 2002 13 : 2371 2380.
10. Vongwiwatana A, Gourishankar S, Campbell PM, Solez K, Halloran PF. Peritubular capillary changes and C4d deposits are associated with transplant glomerulopathy but not IgA nephropathy. Am J Transplant 2004 4 : 124 129.
11. Sijpkens YW, Joosten SA, Wong MC et al. Immunologic risk factors and glomerular C4d deposits in chronic transplant glomerulopathy. Kidney Int 2004 65 : 2409 2418.
12. Behr TM, Feucht HE, Richter K et al. Detection of humoral rejection in human cardiac allografts by assessing the capillary deposition of complement fragment C4d in endomyocardial biopsies. J Heart Lung Transplant 1999 18 : 904 912.
13. Rodriguez ER, Skojec DV, Tan CD et al. Antibody-mediated rejection in human cardiac allografts: Evaluation of immunoglobulins and complement activation products C4d and C3d as markers. Am J Transplant 2005 5 : 2778 2785.
14. Colvin RB, Smith RN. Antibody-mediated organ-allograft rejection. Nat Rev Immunol 2005 5 : 807 817.
15. Poelzl G, Ullrich R, Huber A et al. Capillary deposition of the complement fragment C4d in cardiac allograft biopsies is associated with allograft vasculopathy. Transpl Int 2005 18 : 313 317.
16. Russell PS, Chase CM, Winn HJ, Colvin RB. Coronary atherosclerosis in transplanted mouse hearts. II. Importance of humoral immunity. J Immunol 1994 152 : 5135 5141.
17. Russell PS, Chase CM, Colvin RB. Alloantibody- and T cell-mediated immunity in the pathogenesis of transplant arteriosclerosis: Lack of progression to sclerotic lesions in B cell-deficient mice. Transplantation 1997 64 : 1531 1536.
18. Uehara S, Chase CM, Cornell LD, Madsen JC, Russell PS, Colvin RB. Chronic cardiac transplant arteriopathy in mice: Relationship of alloantibody, C4d deposition and neointimal fibrosis. Am J Transplant 2007 7 : 57 65.
19. Auchincloss H Jr., Sachs DH. Xenogeneic transplantation. Annu Rev Immunol 1998 16 : 433 470.
20. Rahimi S, Qian Z, Layton J, Fox-Talbot K, Baldwin WM 3rd., Wasowska BA. Non-complement- and complement-activating antibodies synergize to cause rejection of cardiac allografts. Am J Transplant 2004 4 : 326 334.
21. Wahrmann M, Exner M, Schillinger M et al. Pivotal role of complement-fixing HLA alloantibodies in presensitized kidney allograft recipients. Am J Transplant 2006 6 (5 Pt 1 1033 1041.
22. Wasowska BA, Qian Z, Cangello DL et al. Passive transfer of alloantibodies restores acute cardiac rejection in IgKO mice. Transplantation 2001 71 : 727 736. (Pubitemid 32377270)
23. Yin D, Zeng H, Ma L et al. Cutting Edge: NK cells mediate IgG1-dependent hyperacute rejection of xenografts. J Immunol 2004 172 : 7235 7238.
24. Bian H, Harris PE, Reed EF. Ligation of HLA class I molecules on smooth muscle cells with anti-HLA antibodies induces tyrosine phosphorylation, fibroblast growth factor receptor expression and cell proliferation. Int Immunol 1998 10 : 1315 1323.
25. Corry RJ, Winn HJ, Russell PS. Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non-H-2 antigens in rejection. Transplantation 1973 16 : 343 350.
26. Russell PS, Chase CM, Sykes M, Ito H, Shaffer J, Colvin RB. Tolerance, mixed chimerism, and chronic transplant arteriopathy. J Immunol 2001 167 : 5731 5740.
27. Armstrong AT, Strauch AR, Starling RC, Sedmak DD, Orosz CG. Morphometric analysis of neointimal formation in murine cardiac allografts. Transplantation 1997 63 : 941 947.
28. Pratt JR, Basheer SA, Sacks SH. Local synthesis of complement component C3 regulates acute renal transplant rejection. Nat Med 2002 8 : 582 587.
29. Smith RN, Brousaides N, Grazette L et al. C4d deposition in cardiac allografts correlates with alloantibody. J Heart Lung Transplant 2005 24 : 1202 1210.
30. Al Aly Z, Yalamanchili P, Cortese C, Salinas-Madrigal L, Bastani B. C4d peritubular capillary staining in chronic allograft nephropathy and transplant glomerulopathy: An uncommon finding. Transpl Int 2005 18 : 800 805.
31. Namba Y, Oka K, Moriyama T et al. Incidence of positive C4d deposition in long-term survival cases over 10 yr after renal transplantation. Clin Transplant 2006 20 (Suppl 15 20 25.
32. Sis B, Campbell PM, Mueller T et al. Transplant glomerulopathy, late antibody-mediated rejection and the ABCD tetrad in kidney allograft biopsies for cause. Am J Transplant 2007 7 : 1743 1752.
33. Sis B, Jhangri G, Bunnag S, Allanch K, Kaplan B, Halloran PF. Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining. Am J Transplant 2009 9 2312 2323.
34. Jin YP, Fishbein MC, Said JW et al. Anti-HLA class I antibody-mediated activation of the PI3K/Akt signaling pathway and induction of Bcl-2 and Bcl-xL expression in endothelial cells. Hum Immunol 2004 65 : 291 302.
35. Jindra PT, Hsueh A, Hong L et al. Anti-MHC class I antibody activation of proliferation and survival signaling in murine cardiac allografts. J Immunol 2008 180 : 2214 2224.
36. Smith JD, Lawson C, Yacoub MH, Rose ML. Activation of NF-kappa B in human endothelial cells induced by monoclonal and allospecific HLA antibodies. Int Immunol 2000 12 : 563 571.
37. Jin YP, Jindra PT, Gong KW, Lepin EJ, Reed EF. Anti-HLA class I antibodies activate endothelial cells and promote chronic rejection. Transplantation 2005 79 (3 Suppl S19 S21.
38. Lepin EJ, Jin YP, Barwe SP, Rozengurt E, Reed EF. HLA class I signal transduction is dependent on Rho GTPase and ROK. Biochem Biophys Res Commun 2004 323 : 213 217.
39. Jindra PT, Jin YP, Rozengurt E, Reed EF. HLA class I antibody-mediated endothelial cell proliferation via the mTOR pathway. J Immunol 2008 180 : 2357 2366.
40. Lee CY, Lotfi-Emran S, Erdinc M et al. The involvement of FcR mechanisms in antibody-mediated rejection. Transplantation 2007 84 : 1324 1334.
41. Hirohashi T, Uehara S, Chase CM et al. Evidence for NK cell involvement in non-complement mediated transplant vasculopathy [abstract]. In : International Transplant Congress. Sydney, Australia, 2008.
42. Colvin RB, Nickeleit V. Renal transplant pathology, 6th Ed. Philadelphia : Lippincott-Raven, 2006.
43. Russell PS, Chase CM, Winn HJ, Colvin RB. Coronary atherosclerosis in transplanted mouse hearts. I. Time course and immunogenetic and immunopathological considerations. The American journal of pathology 1994 144 : 260 274.
44. Solez K, Colvin RB, Racusen LC et al. Banff '05 Meeting Report: Differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant 2007 7 : 518 526.